期刊
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
卷 13, 期 4, 页码 277-288出版社
WILEY
DOI: 10.1111/ajco.12698
关键词
autoimmune; CTLA4; immunotherapy; PD1; PDL1
类别
Immune checkpoint inhibitors have recently emerged as an exciting new treatment paradigm across a broad spectrum of malignancies. This new class of agents also challenges oncologists with a unique set of immune-based toxicities. Early recognition and precise management of these toxicities can result in better outcomes, with minimization of toxicity and harm to the patient. This article provides a comprehensive review of immune-based toxicities caused by immune checkpoint inhibitors, including recommendations for their investigation and guidelines for specific management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据